NCT06187922View on ClinicalTrials.gov

Effect of Perioperative Oral Pregabalin in Total Knee Replacement

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

July 30, 2025

Conditions
Postoperative Pain
Interventions
DRUG

Pregabalin 75mg

Group pregabalin will receive cap pregabalin 75mg as premedication and will continue as B.D dose for 72 Hrs.

PROCEDURE

adductor canal block

Both group will receive ultrasound guided Adductor canal block with bupivacaine 0.2% 20-30ml and dexmedetomidine 1mcg/Kg

Trial Locations (1)

323

RECRUITING

Bahrain Defence Force, Manama

All Listed Sponsors
lead

Bahrain Defence Force Hospital

OTHER